雜志介紹

Pharmacogenomics Journal雜志介紹

《Pharmacogenomics Journal》是一本以English為主的未開放獲取國際優秀期刊，中文名稱藥物基因組學雜志，本刊主要出版、報道醫學-GENETICS & HEREDITY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.9，最新CiteScore 指數為7.2。

本刊近期中國學者發表的論文主要有：

• Two common mutations within CYP2C19 affected platelet aggregation in Chinese patients undergoing PCI: a one-year follow-up study.

  Author: Wang Z¹, Liu Z¹, Wang W², Fu Y¹, Chen W¹, Li W¹, Zhang X³, Tang Y⁴, Zhou Z⁵.

• HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions.

  Author: Yan S¹, Xiong H², Shao F³, Zhang W⁴, Yang F², Qi Z¹, Chen S², He L^1,5, Jiang M¹, Su Y¹, Zhu H¹, Qin S^1,5, Zhu Q², Luo X⁶, Xing Q⁷.

• Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients.

  Author: Si S^1,2, Wang Z¹, Yang H¹, Han Z¹, Tao J¹, Chen H¹, Wang K¹, Guo M², Tan R¹, Wei JF^3,4, Gu M⁵.

• Precision dosing of warfarin: open questions and strategies.

  Author: Li X^1,2, Li D^1,2, Wu JC³, Liu ZQ^1,2, Zhou HH^1,2, Yin JY^4,5,6.

英文介紹

Pharmacogenomics Journal雜志英文介紹

The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications.

Key areas of coverage include:

Personalized medicine

Effects of genetic variability on drug toxicity and efficacy

Identification and functional characterization of polymorphisms relevant to drug action

Pharmacodynamic and pharmacokinetic variations and drug efficacy

Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics

Clinical applications of genomic science

Identification of novel genomic targets for drug development

Potential benefits of pharmacogenomics.